Natalie Matthews

Dr. Natalie Matthews


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Cancer Epidemiology, Biomarkers & Prevention
Verified
Journal Article
Closed access
PDF file
NMNatalie Matthews
Natalie Matthews
KFKatherine Fitch
Katherine Fitch
WLWen-Qing Li
Wen-Qing Li
JMJ. Steven Morris
J. Steven Morris
DCDavid C. Christiani
David C. Christiani
ECEunyoung Cho
Eunyoung Cho
Exposure to environmental trace elements has been studied in relation to many cancers. However, an association between exposure to trace elements and skin cancer remains less understood. Therefore, we conducted a systematic review of published epidemiologic literature examining the association between exposure to trace elements, and risk of melanoma and keratinocyte carcinoma in humans. We identified epidemiologic studies investigating exposure to arsenic, cadmium, chromium, copper, iron, selenium, and zinc and risk of skin cancer in humans. Among the minerals, arsenic, selenium, and zinc had more than five studies available. Exposure to arsenic was associated with increased risk of keratinocyte carcinoma, while too few studies existed on melanoma to draw conclusions. Exposure to selenium was associated with possible increased risk of keratinocyte carcinoma. Studies of zinc and skin cancer were case–control in design and were found to have inconsistent associations. The data on the association between cadmium, chromium, copper, and iron and risk of skin cancer remain too sparse to draw any conclusions. In summary, epidemiologic studies on exposure to trace elements and cutaneous malignancies are limited. Studies with larger sample sizes and prospective designs are warranted to improve our knowledge of trace elements and skin cancer.

1 September 2019 in Cancer Epidemiology, Biomarkers & Prevention
Verified
Journal Article
Closed access
PDF file
NMNatalie Matthews
Natalie Matthews
MKMichelle Koh
Michelle Koh
WLWen-Qing Li
Wen-Qing Li
TLTricia Li
Tricia Li
WWWalter Willett
Walter Willett
ECEunyoung Cho
Eunyoung Cho
Background: Few epidemiologic studies have investigated trace element exposure and skin cancer risk. Methods: Toenail levels of mercury, selenium, chromium, iron, and zinc were measured from 6,708 women in the Nurses9 Health Study (1984–2012) and 3,730 men in the Health Professionals Follow-up Study (1986–2012) with data from prior nested case–control studies. Participants were free of skin cancer at toenail collection and followed for incident basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and melanoma. Cox proportional hazards models were used to compute hazard ratios (HR) and 95% confidence intervals (CI) of skin cancer associated with the elements in each study. We calculated pooled multivariable HRs using a fixed-effects model. During 26 to 28 years of follow-up, 2,433 BCC, 334 SCC, and 130 melanoma cases were documented. Results: Higher toenail mercury levels were associated with risk of BCC [pooled HR for top vs. bottom quintiles = 1.34 (95% CI, 1.18–1.52), Ptrend < 0.0001]. Similar direct associations were found with risks of SCC [pooled HR for top vs. bottom quartiles = 1.41 (95% CI, 1.03–1.94), Ptrend = 0.04] and melanoma [pooled HR for top vs. bottom quartiles = 1.88 (95% CI, 1.12–3.16), Ptrend = 0.02]. Chromium was positively associated with BCC in women only. No associations were found between other metals and skin cancer risk. Conclusions: Our prospective data found that increased toenail mercury concentrations were associated with increased skin cancer risk. Impact: If our novel findings are confirmed, mercury may play a role in skin carcinogenesis.

1 January 2019 in Cancer Epidemiology, Biomarkers & Prevention
Verified
Journal Article
Closed access
PDF file
WLWen-Qing Li
Wen-Qing Li
ECEunyoung Cho
Eunyoung Cho
SWShaowei Wu
Shaowei Wu
SLSuyun Li
Suyun Li
NMNatalie Matthews
Natalie Matthews
AQAbrar A. Qureshi
Abrar A. Qureshi
Background: Several host characteristics, including pigmentary traits (hair color, sunburn susceptibility and tanning ability), number of common nevi (moles), and family history of melanoma, have been associated with risk of melanoma. Methods: We prospectively examined the associations between host characteristics and risk of incident melanoma by Breslow thickness (≤1 mm, thin melanoma; or >1 mm, “thicker melanoma”) based on the Nurses' Health Study (NHS, n = 86,380 women), NHS II (n = 104,100 women), and Health Professionals Follow-up Study (HPFS, n = 46,934 men). Results: During 22–30 years' follow-up, a total of 1,813 incident melanoma cases were identified with information on Breslow thickness, 1,392 (76.8%) of which had thin melanoma. No significant differences were observed for thin and thicker melanoma in associations with hair color, sunburn susceptibility, and tanning ability. However, we found significant differences for the association with family history of melanoma, with a higher risk estimate for thicker melanoma [HR = 2.55; 95% confidence interval (CI): 1.91–3.42] than thin melanoma (HR = 1.59; 95% CI: 1.21–2.08; Pheterogeneity = 0.02). Interestingly, women and men displayed differential associations between nevi count and risk of melanoma by Breslow thickness, with the association appearing stronger for thicker melanoma than thin melanoma in men (Pheterogeneity = 0.01), but not in women. Conclusions: Individuals with family history of melanoma may be more likely to develop thicker melanoma. Men with high number of common nevi may tend to develop thicker melanoma, which was not found for women. Impact: The findings further stress the risk of thicker melanoma for individuals with a family history of melanoma and men with a high nevi count.

5 September 2018 in British Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
NMNatalie Matthews
Natalie Matthews
PRP.M. Risica
P.M. Risica
LFL.K. Ferris
L.K. Ferris
MBM. Beatson
M. Beatson
MSM. Saul
M. Saul
MWM.A. Weinstock
M.A. Weinstock

22 July 2022 in Australasian Journal of Dermatology
Verified
Journal Article
Open access
CRC. Yoonhee Ryder
C. Yoonhee Ryder
NMNatalie Matthews
Natalie Matthews
LLLori Lowe
Lori Lowe
FWFrank Wang
Frank Wang
We describe a strikingly robust presentation of trimethoprim‐sulfamethoxazole (TMP‐SMX)‐induced pustular Sweet syndrome and discuss how to distinguish it from iododerma and other neutrophil‐rich conditions. A review of the literature indicates that TMP‐SMX‐induced Sweet syndrome (SS) may have higher rates of neutrophilia and greater ocular, mucosal, and musculoskeletal involvement compared to SS from other drugs. Recognizing these features and identifying the offending agent are critical for correctly diagnosing TMP‐SMX‐induced SS in a timely manner.

NMNatalie Matthews
Natalie Matthews
Augustine W. KangAugustine W. Kang
Augustine W. Kang
MWMartin A. Weinstock
Martin A. Weinstock
PRPatricia Risica
Patricia Risica
Skin cancer incidence in the United States has risen rapidly in recent decades, underscoring the need for accessible and effective prevention practices. Skin cancer prevention counseling can lead to increased sun protective behavior and early detection; however, little is understood regarding the frequency and content of counseling among primary care providers (PCPs). We performed multi-center cross-sectional surveys among 53 providers and 3343 of their patients and chart review asking whether skin cancer prevention counseling occurred and details of that counseling. Only 10–25% of patients reported that counseling occurred. Among the providers who reported counseling, there were higher odds that their patients recollected they were advised to use sunscreen or protective clothing, on how to use sunscreen, on signs of skin cancer, to perform a self-skin exam (all p < 0.001), and were provided with written materials (p < 0.01). Eight percent of prevention counseling was chart documented despite being highly associated with patient and physician recollection of counseling (p < 0.001). These results highlight the need for consistent and clear delivery of skin cancer primary prevention.